+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Malabsorption Syndrome Drug"

Malabsorption Syndrome Market - Global Forecast 2025-2032 - Product Thumbnail Image

Malabsorption Syndrome Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 195 Pages
  • Global
From
Malabsorption Syndrome - Global Strategic Business Report - Product Thumbnail Image

Malabsorption Syndrome - Global Strategic Business Report

  • Report
  • October 2025
  • 185 Pages
  • Global
From
From
Malabsorption Syndrome Market 2024-2028 - Product Thumbnail Image

Malabsorption Syndrome Market 2024-2028

  • Report
  • July 2024
  • 138 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Malabsorption Syndrome Drugs are a type of Gastrointestinal Drugs used to treat malabsorption syndrome, a condition in which the body is unable to absorb nutrients from food. These drugs are used to replace the missing nutrients and help the body absorb them. Commonly used drugs include pancreatic enzymes, bile acid sequestrants, and probiotics. Pancreatic enzymes are used to replace the enzymes that the pancreas is unable to produce, while bile acid sequestrants are used to bind bile acids and prevent them from being reabsorbed. Probiotics are used to restore the balance of beneficial bacteria in the gut. Some companies in the Malabsorption Syndrome Drug market include AbbVie, Allergan, AstraZeneca, Bayer, GlaxoSmithKline, Merck, Novartis, Pfizer, and Takeda. Show Less Read more